Stable nonviral gene transfer into primary human T cells

Human Gene Therapy

Volumn 20, Issue 9, 2009, Pages 989-998

  Magg, T ^a   Hartrampf, S ^a   Albert, M H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; DNA MODIFICATION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PROMOTER REGION; RNA TRANSLATION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ELECTROPORATION; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOMAGNETIC SEPARATION; LYMPHOCYTE ACTIVATION; NERVE GROWTH FACTORS; PLASMIDS; T-LYMPHOCYTES; TRANSFECTION;

EID: 70349087818     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.180     Document Type: Article

References (24)

1. Berger, C., Blau, C.A., Clackson, T., Riddell, S.R., and Heimfeld, S. (2003). CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy. Blood 101, 476-484.
2. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., and Bordignon, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
3. Bonini, C., Grez, M., Traversari, C., Ciceri, F., Marktel, S., Ferrari, G., Dinauer, M., Sadat, M., Aiuti, A., Deola, S., Radrizzani, M., Hagenbeek, A., Apperley, J., Ebeling, S., Martens, A., Kolb, H.J., Weber, M., Lotti, F., Grande, A., Weissinger, E., Bueren, J.A., Lamana, M., Falkenburg, J.H., Heemskerk, M.H., Austin, T., Kornblau, S., Marini, F., Benati, C., Magnani, Z., Cazzani-ga, S., Toma, S., Gallo-Stampino, C., Introna, M., Slavin, S., Greenberg, P.D., Bregni, M., Mavilio, F., and Bordignon, C. (2003). Safety of retroviral gene marking with a truncated NGF receptor. Nat. Med. 9, 367-369.
4. Bordignon, C., Bonini, C., Verzeletti, S., Nobili, N., Maggioni, D., Traversari, C., Giavazzi, R., Servida, P., Zappone, E., Benazzi, E., Bernardi, M., Porta, F., Ferrari, G., Mavilio, F., Rossini, S. Blaese R.M. Candotti, F., Blaese, R.M., and Candotti, F. (1995). Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. Hum. Gene Ther. 6, 813-819.
5. Dardalhon, V., Herpers, B., Noraz, N., Pflumio, F., Guetard, D., Leveau, C., Dubart-Kupperschmitt, A., Charneau, P., and Taylor, N. (2001). Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 8, 190-198.
6. Fehse, B., Uhde, A., Fehse, N., Eckert, H.G., Clausen, J., Ruger, R., Koch, S., Ostertag, W., Zander, A.R., and Stockschlader, M. (1997). Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an in-tracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (DLNGFR) gene. Hum. Gene Ther. 8, 1815-1824.
7. Gaines, P., and Wojchowski, D.M. (1999). pIRES-CD4t, a dicis-tronic expression vector for MACS- or FACS-based selection of transfected cells. Biotechniques 26, 683-688.
8. Goffinet, C., and Keppler, O.T. (2006). Efficient nonviral gene delivery into primary lymphocytes from rats and mice. FASEB J. 20, 500-502.
9. Gresch, O., Engel, F.B., Nesic, D., Tran, T.T., England, H.M., Hickman, E.S., Korner, I., Gan, L., Chen, S., Castro-Obregon, S., Hammermann, R., Wolf, J., Muller-Hartmann, H., Nix, M., Siebenkotten, G., Kraus, G., and Lun, K. (2004). New non-viral method for gene transfer into primary cells. Methods 33, 151-163.
10. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Mac-intyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., and Cavazzana-Calvo, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
11. Hamm, A., Krott, N., Breibach, I., Blindt, R., and Bosserhoff, A.K. (2002). Efficient transfection method for primary cells. Tissue Eng. 8, 235-245
12. Heslop, H.E., Ng, C.Y., Li, C., Smith, C.A., Loftin, S.K., Krance, R.A., Brenner, M.K., and Rooney, C.M. (1996). Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2, 551-555.
13. Holtkamp, B., Cramer, M., Lemke, H., and Rajewsky, K. (1981). Isolation of a cloned cell line expressing variant H-2Kk using fluorescence-activated cell sorting. Nature 289, 66-68.
14. Kohn, D.B., Sadelain, M., and Glorioso, J.C. (2003). Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3, 477-488.
15. Kozak, M. (1999). Initiation of translation in prokaryotes and eukaryotes. Gene 234, 187-208.
16. Lai, W., Chang, C.H., and Farber, D.L. (2003). Gene transfection and expression in resting and activated murine CD4 T cell subsets. J. Immunol. Methods 282, 93-102.
17. Magg, T., and Albert, M.H. (2007). Tracking cell proliferation using the far red fluorescent dye SNARF-1. Cytometry B Clin. Cytom. 72, 458-464.
18. Phillips, K., Gentry, T., McCowage, G., Gilboa, E., and Smith, C. (1996). Cell-surface markers for assessing gene transfer into human hematopoietic cells. Nat. Med. 2, 1154-1156.
19. Pule, M.A., Savoldo, B., Myers, G.D., Rossig, C., Russell, H.V., Dotti, G., Huls, M.H., Liu, E., Gee, A.P., Mei, Z., Yvon, E., Weiss, H.L., Liu, H., Rooney, C.M., Heslop, H.E., and Brenner, M.K. (2008). Virus-specific T cells engineered to coexpress tumor-specific receptors: Persistence and antitumor activity in individuals with neuroblastoma. Nat. Med. 14, 1264-1270.
20. Schakowski, F., Buttgereit, P., Mazur, M., Marten, A., Schottker, B., Gorschluter, M., and Schmidt-Wolf, I.G. (2004). Novel non-viral method for transfection of primary leukemia cells and cell lines. Genet. Vaccines Ther. 2, 1.
21. Schneider, S., and Rusconi, S. (1996). Magnetic selection of transiently transfected cells. Biotechniques 21, 876-880.
22. Tahvanainen, J., Pykalainen, M., Kallonen, T., Lahteenmaki, H., Rasool, O., and Lahesmaa, R. (2006). Enrichment of nucleo-fected primary human CD4+ T cells: A novel and efficient method for studying gene function and role in human primary T helper cell differentiation. J. Immunol. Methods 310, 30-39.
23. Van Tendeloo, V.F., Willems, R., Ponsaerts, P., Lenjou, M., Nijs, G., Vanhove, M., Muylaert, P., Van Cauwelaert, P., Van Broeckhoven, C., Van Bockstaele, D.R., and Berneman, Z.N. (2000). High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery. Gene Ther. 7, 1431-1437.
24. Yu, X., Zhan, X., D'costa, J., Tanavde, V.M., Ye, Z., Peng, T., Malehorn, M.T., Yang, X., Civin, C.I., and Cheng, L. (2003). Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol. Ther. 7, 827-838.